MainReads
← Details
Extracorporeal photopheresis for the treatment of steroid-refractory immune related adverse events from immune checkpoint inhibitor therapy: a multi-center phase Ib/II clinical trial.
Riemer R, Braun LM, Giesler S, Rafei-Shamsabadi D, Haferkamp S, Hartmann A, Melchinger W, Weiss M, Birth S, Philipp U, Gebhard I, Schwänen C, Hutchinson JA, Karantzelis N, Wallrabenstein T, Lowinus T, Brehm N, Rawluk J, Pfeifer D, Osswald N, Bronsert P, Rogg M, Andreev G, Boerries M, Lammer M, Nguyen VA, Schmuth M, Köhler N, Duyster J, Ihorst G, Keye P, Minguet S, Schadendorf D, Ugurel S, Thimme R, Hasselblatt P, Pearce EL, Becher B, Funke-Lorenz C, Scherer F, Bengsch B, Schell C, Placke JM, Meiss F, Apostolova P, Zeiser R
/
-
Loading document from repository...
Unable to Display Document
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.